BioPep’s New Book Looks at Novel Regenerative Therapies for Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the brain and spinal cord. In MS, inflammation destroys the fatty sheath that protects the nerve fibres (myelin). This causes damage to nerve cells, nerve fibres, and the cells that produce the myelin (oligodendrocytes). 

The damage to the myelin interferes with the central nervous system (CNS) messages that go from the brain to the rest of the body, resulting in disability that is potentially debilitating, depending on its severity.

The cause of MS is not known, though it is believed to be triggered by a combination of factors (genetic, immunological, and/or environmental). Some genetic variations found in MS are shared by different autoimmune diseases, suggesting underlying similarities between them. 

Autoimmune diseases involve the immune system attacking a part of the body, causing inflammation and damage to that area. 

The most widely accepted hypothesis of MS is that it is an autoimmune disease that affects genetically predisposed individuals who encounter an unknown factor in their environment. This may explain why the disease has different manifestations. The progression, severity and symptoms of MS are different for each person with the disease.

Although the underlying mechanisms of autoimmune disease are not fully understood, scientists are constantly learning more about the intricacies of the immune system and how disease treatments can harness these processes. Studies over the few past decades have indicated that most autoimmune diseases also have an environmental influence. 

MS is a common disease, and most people know someone with it. According to the National MS Society, there are nearly 1 million people are living with MS in the United States alone. 

There is currently no cure for MS but there is an urgent unmet need to find one. Many specialists and patients confronted with MS have become disillusioned with the therapies currently available. 

Existing medicines for MS fall into three groups: those that reduce the risk of relapses and slow down disease progression (also known as disease-modifying therapies or DMTs), those that treat an active relapse, or those that help alleviate specific symptoms.

DMTs are immunmodulators, which are medications that work by modifying the activity of the immune system to reduce it attacking the CNS. These have been shown to slow the frequency and intensity of attacks on the immune system.

Corticosteroids are another medication used in MS and are given either intravenously or orally to reduce inflammation and reduce acute relapses. However, these can cause other harmful side effects and are intended for short term use only.

Medications and lifestyle changes can be used to manage other MS symptoms such as bladder problems, tiredness, pain, spasticity, depression, anxiety and stress. 

Recently, novel regenerative therapies have been developed for MS. Regenerative treatments are intended to repair and replace injured cells and tissues with new ones. Promising new bioregenerative technologies offer exciting therapeutic options for inflammatory-related diseases. 

At BioPep, we believe that better health is possible using scientifically tested products and technologies that harness the power of our immune system. 

Our new book, Multiple Sclerosis Practical Comprehensive Essentials, explains how the immune system works and provides insights into the ways in which bioregenerative medicine can be used to fight disease, inflammation and aging.

It provides a comprehensive overview of the current knowledge on the underlying processes involved in MS and explains the existing and developing treatments that target these. 

The book introduces the reader to the theoretical background and clinical features of the disease. It outlines the various interventions that have been suggested in recent years to stimulate and rejuvenate the immune system, which have potential benefit for those with MS. 

It then reviews novel regenerative treatment strategies that accelerate biological mechanisms of repair and provide an alternative approach to MS management, such as immunomodulators, Transfer Factor therapy and Active Specific Immunotherapy (ASI) Therapy.

This provides holistic biological approaches to the management of MS to slow disease progression in some patients, and increase the repair and recovery of brain and spinal cord cells. It is hoped that this book will help give people with MS the ability to continue to enjoy a full and active life after a diagnosis.

This book was written with inspiration from the positive and long-term results obtained by clinicians using these technologies around the world. BioPep is an R&D biotech company, a subsidiary of European Wellness Biomedical Group (EW) that is focused on the scientific study of existing products manufactured by European Wellness Biomedical Group, as well as developing innovative new products in collaboration with a Colorado-based US FDA registered facility. 

Our organopeptides, which are Nano Organo Peptides or Mito Organelles (NOPs and MOs), are manufactured by European Wellness Biomedical Group at the EW facility in Europe who are committed to ensuring that all organopeptide products are pathogen-free and safe. 

We partner with top-tier research institutions, universities, and manufacturing facilities to provide data on the effectiveness of organ-specific peptides’ ability to rejuvenate and improve health.

References:

Chan, M. and Tulina, D. (2022). Multiple Sclerosis – Practical Comprehensive Essentials. Troubador. SKU: ISBN978-1-80313-118-4

Similar Posts